Clinical Trial Update: Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on DKF-MA102 for prostate cancer, with ongoing recruitment and no results reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DKF-MA102

Snippet

Sponsor: Dongkook Pharmaceutical Co., Ltd. | Conditions: Advanced Prostate Cancer | Phase 3 | Status: RECRUITING